BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34791809)

  • 21. Impact of osteopenia on surgical and oncological outcomes in patients with pancreatic cancer.
    Abe K; Furukawa K; Okamoto T; Matsumoto M; Futagawa Y; Haruki K; Shirai Y; Ikegami T
    Int J Clin Oncol; 2021 Oct; 26(10):1929-1937. PubMed ID: 34232427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computerized tomography scan in pre-diagnostic pancreatic ductal adenocarcinoma: Stages of progression and potential benefits of early intervention: A retrospective study.
    Singh DP; Sheedy S; Goenka AH; Wells M; Lee NJ; Barlow J; Sharma A; Kandlakunta H; Chandra S; Garg SK; Majumder S; Levy MJ; Takahashi N; Chari ST
    Pancreatology; 2020 Oct; 20(7):1495-1501. PubMed ID: 32950386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ketogenic Diets in Pancreatic Cancer and Associated Cachexia: Cellular Mechanisms and Clinical Perspectives.
    Cortez NE; Mackenzie GG
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated malnutrition and muscle wasting.
    Dong J; Yu J; Li Z; Gao S; Wang H; Yang S; Wu L; Lan C; Zhao T; Gao C; Liu Z; Wang X; Hao J
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):704-716. PubMed ID: 33763996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function.
    Bachmann J; Ketterer K; Marsch C; Fechtner K; Krakowski-Roosen H; Büchler MW; Friess H; Martignoni ME
    BMC Cancer; 2009 Jul; 9():255. PubMed ID: 19635171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative body composition is influenced by the stage of operable pancreatic adenocarcinoma but does not predict survival after Whipple's procedure.
    Aslani A; Gill AJ; Roach PJ; Allen BJ; Smith RC
    HPB (Oxford); 2010 Jun; 12(5):325-33. PubMed ID: 20590908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity of weight loss and transcriptomic signatures in pancreatic ductal adenocarcinoma.
    Riner AN; Herremans KM; Vudatha V; Han S; Qu X; Liu J; Mukhopadhyay N; Freudenberger DC; George TJ; Judge SM; Judge AR; Hughes SJ; Trevino JG
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):149-158. PubMed ID: 38123146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes associated with pancreatic ductal adenocarcinoma is just diabetes: Results of a prospective observational study in surgical patients.
    Dugnani E; Gandolfi A; Balzano G; Scavini M; Pasquale V; Aleotti F; Liberati D; Di Terlizzi G; Petrella G; Reni M; Doglioni C; Bosi E; Falconi M; Piemonti L
    Pancreatology; 2016; 16(5):844-52. PubMed ID: 27546476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nutritional and immune impairments and their effects on outcomes in early pancreatic cancer patients undergoing pancreatoduodenectomy.
    Tumas J; Tumiene B; Jurkeviciene J; Jasiunas E; Sileikis A
    Clin Nutr; 2020 Nov; 39(11):3385-3394. PubMed ID: 32184025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer.
    Burfeind KG; Zhu X; Norgard MA; Levasseur PR; Huisman C; Buenafe AC; Olson B; Michaelis KA; Torres ER; Jeng S; McWeeney S; Raber J; Marks DL
    Elife; 2020 May; 9():. PubMed ID: 32391790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of a mouse model of pancreatic cancer to simulate the human phenotypes of metastasis and cachexia.
    Spadafora V; Pryce BR; Oles A; Talbert EE; Romeo M; Vaena S; Berto S; Ostrowski MC; Wang DJ; Guttridge DC
    BMC Cancer; 2024 Apr; 24(1):414. PubMed ID: 38570770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased myocellular lipid and IGFBP-3 expression in a pre-clinical model of pancreatic cancer-related skeletal muscle wasting.
    Cole CL; Bachman JF; Ye J; Murphy J; Gerber SA; Beck CA; Boyce BF; Muthukrishnan G; Chakkalakal JV; Schwarz EM; Linehan D
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):731-745. PubMed ID: 33960737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Handgrip Strength Predicts Survival in Patients With Pancreatic Cancer.
    Freckelton J; Rajagopalan A; Moore GT; Croagh D
    Pancreas; 2024 May; 53(5):e405-e409. PubMed ID: 38517481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment and characterization of a novel murine model of pancreatic cancer cachexia.
    Michaelis KA; Zhu X; Burfeind KG; Krasnow SM; Levasseur PR; Morgan TK; Marks DL
    J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):824-838. PubMed ID: 28730707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cachexia and pancreatic cancer: are there treatment options?
    Mueller TC; Burmeister MA; Bachmann J; Martignoni ME
    World J Gastroenterol; 2014 Jul; 20(28):9361-73. PubMed ID: 25071331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orthotopic model of human pancreatic ductal adenocarcinoma and cancer cachexia in nude mice.
    Jones-Bolin S; Ruggeri B
    Curr Protoc Pharmacol; 2007 Jun; Chapter 14():Unit 14.3. PubMed ID: 21948162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular resection for locally advanced pancreatic ductal adenocarcinoma: analysis of long-term outcomes from a single-centre series.
    Feo CF; Deiana G; Ninniri C; Cherchi G; Crivelli P; Fancellu A; Ginesu GC; Porcu A
    World J Surg Oncol; 2021 Apr; 19(1):126. PubMed ID: 33866970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CT- and MRI-Based Assessment of Body Composition and Pancreatic Fibrosis Reveals High Incidence of Clinically Significant Metabolic Changes That Affect the Quality of Life and Treatment Outcomes of Patients with Chronic Pancreatitis and Pancreatic Cancer.
    Bieliuniene E; Brøndum Frøkjær J; Pockevicius A; Kemesiene J; Lukosevičius S; Basevicius A; Atstupenaite V; Barauskas G; Ignatavicius P; Gulbinas A; Dambrauskas Z
    Medicina (Kaunas); 2019 Sep; 55(10):. PubMed ID: 31569661
    [No Abstract]   [Full Text] [Related]  

  • 40. Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia.
    Di Sebastiano KM; Yang L; Zbuk K; Wong RK; Chow T; Koff D; Moran GR; Mourtzakis M
    Br J Nutr; 2013 Jan; 109(2):302-12. PubMed ID: 23021109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.